SCHEDULE: Park Ha Biological Technology Stakeholder Update

Velociti Group Limited and Chunxin Xia report beneficial ownership of 9.8% of Park Ha Biological Technology's Class A Ordinary Shares, including exercisable warrants.

Summary

• Velociti Group Limited and Chunxin Xia have jointly filed a Schedule 13G, indicating their beneficial ownership of Park Ha Biological Technology Co., Ltd. Class A Ordinary Shares.
• The total beneficial ownership reported is 422,500 shares, representing 9.8% of the class.
• This ownership includes 260,000 shares underlying warrants that are exercisable within the next 60 days.
• The calculation of the percentage is based on 2,297,902 Class A Ordinary Shares outstanding as of August 3, 2026, following a reverse stock split effective August 6, 2026, plus an additional 2,000,000 shares underlying warrants exercisable within 60 days.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership and warrant exerciseability, with no significant new financial or strategic information.

Positives

• Reporting of increased stake or potential stake through exercisable warrants can signal confidence from investors.
• The filing clarifies ownership structure and potential future shareholding.

Negatives

• The filing does not provide any new financial performance data or strategic updates for the company itself.

Risks

• The exercisability of warrants within 60 days introduces potential dilution for existing shareholders if exercised.
• Changes in beneficial ownership, even if not for control, can sometimes precede other strategic moves by significant shareholders.

Future Outlook

The filing does not contain forward-looking statements or guidance from the company. The only forward-looking aspect relates to the exercisability of warrants within the next 60 days.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant shareholders to report their holdings. This filing indicates a notable stake in Park Ha Biological Technology, which operates in the biotechnology sector, a field often characterized by significant capital requirements and potential for rapid growth or setbacks.

Stakeholder Impact

• Shareholders may experience potential dilution if the warrants are exercised.
• The increased reporting of beneficial ownership might influence investor perception of the company's shareholder base.

Next Steps

• The reporting persons may exercise their warrants within the next 60 days, which could increase their shareholding.
• The company may proceed with its reverse stock split as planned, effective August 6, 2026.

Key Dates

Keywords

Park Ha Biological Technology, Schedule 13G, Beneficial Ownership, Class A Ordinary Shares, Warrants, Velociti Group Limited, Chunxin Xia, Reverse Stock Split